tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ENTA Stock Latest News

Is ENTA a Buy, Before Earnings?
Pre-EarningsIs ENTA a Buy, Before Earnings?
1d ago
ENTA
Enanta Pharmaceuticals Stockholders Approve Key Proposals in 2025
PremiumCompany Announcements
Enanta Pharmaceuticals Stockholders Approve Key Proposals in 2025
2M ago
8K
ENTA
Enanta Pharmaceuticals: Hold Rating Amid Delayed Launches and Strategic Advancements
PremiumRatings
Enanta Pharmaceuticals: Hold Rating Amid Delayed Launches and Strategic Advancements
3M ago
ENTA
Enanta Pharmaceuticals Advances in Virology and Immunology
PremiumCompany Announcements
Enanta Pharmaceuticals Advances in Virology and Immunology
3M ago
ENTA
Enanta CEO buys $256K in common stock
PremiumThe Fly
Enanta CEO buys $256K in common stock
3M ago
ENTA
Enanta Pharmaceuticals: Buy Rating Driven by Promising RSV Developments and Strategic Plans
PremiumRatingsEnanta Pharmaceuticals: Buy Rating Driven by Promising RSV Developments and Strategic Plans
3M ago
ENTA
Enanta reports Q1 EPS ($1.05), consensus ($1.35)
Premium
The Fly
Enanta reports Q1 EPS ($1.05), consensus ($1.35)
3M ago
ENTA
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
3M ago
ENTA
Enanta to appeal ruling related to ‘953 patent infringement lawsuit
PremiumThe Fly
Enanta to appeal ruling related to ‘953 patent infringement lawsuit
5M ago
PFE
ENTA
Enanta price target lowered to $18 from $27 at H.C. Wainwright
PremiumThe Fly
Enanta price target lowered to $18 from $27 at H.C. Wainwright
5M ago
ENTA
Enanta price target lowered to $20 from $30 at Evercore ISI
PremiumThe Fly
Enanta price target lowered to $20 from $30 at Evercore ISI
5M ago
ENTA
Enanta Pharmaceuticals Reports Promising Results for Pediatric RSV Drug
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Promising Results for Pediatric RSV Drug
5M ago
8K
ENTA
Enanta announces ‘positive’ results from Phase 2 study of zelicapavir
PremiumThe FlyEnanta announces ‘positive’ results from Phase 2 study of zelicapavir
5M ago
ENTA
Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility
Premium
Company Announcements
Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility
5M ago
ENTA
Enanta price target lowered to $14 from $16 at Oppenheimer
Premium
The Fly
Enanta price target lowered to $14 from $16 at Oppenheimer
6M ago
ENTA
Enanta price target lowered to $20 from $26 at Baird
PremiumThe Fly
Enanta price target lowered to $20 from $26 at Baird
6M ago
ENTA
Enanta price target lowered to $21 from $22 at JMP Securities
PremiumThe Fly
Enanta price target lowered to $21 from $22 at JMP Securities
6M ago
ENTA
Enanta Pharmaceuticals Reports Q4 2024 Financials
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Q4 2024 Financials
6M ago
ENTA
Closing Bell Movers: Semtech rises, Zoom falls after earnings
PremiumThe Fly
Closing Bell Movers: Semtech rises, Zoom falls after earnings
6M ago
ZM
KSS
Enanta reports Q4 EPS ($1.36), consensus (92c)
PremiumThe FlyEnanta reports Q4 EPS ($1.36), consensus (92c)
6M ago
ENTA
Enanta Pharmaceuticals (ENTA) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Enanta Pharmaceuticals (ENTA) Q4 Earnings Cheat Sheet
6M ago
ENTA
Enanta’s EDP-323 meets Phase 2a endpoints in respiratory syncytial virus
Premium
The Fly
Enanta’s EDP-323 meets Phase 2a endpoints in respiratory syncytial virus
8M ago
ENTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >